University of British Columbia to Perform Clinical Study on the Cardiovascular and Cognitive Health Effects of Lexaria’s TurboCBDTM. Cannabis Investing News
Software Company Strainprint Wants to Change the Limitations of Medical Cannabis Research Cannabis Investing News
Isodiol International Inc. Announces Distribution Agreement for South America Cannabis Investing News
ABcann Global files Q2 2017 Financial Results and Provides Operational Update Cannabis Investing News
